Loco-regional tumor control was highly affected by PTEN expression: 5-year LRC was 52.3% in patients with low PTEN expression, compared to 80.9% in patients with high PTEN expression (p = 0.0007, Fig. 2A). This evidence concerns the gene PTEN and neoplasm.